PMID- 27539837 OWN - NLM STAT- MEDLINE DCOM- 20170501 LR - 20181113 IS - 1535-5667 (Electronic) IS - 0161-5505 (Print) IS - 0161-5505 (Linking) VI - 58 IP - 2 DP - 2017 Feb TI - 2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine PET. PG - 326-331 LID - 10.2967/jnumed.116.176891 [doi] AB - The objective of this study was to detect regional patterns of cardiac sympathetic denervation in idiopathic Parkinson disease (IPD) using (11)C-hydroxyephedrine ((11)C-HED) PET and determine the denervation rate over 2 y. METHODS: We obtained 62 cardiac (11)C-HED PET scans in 39 patients (30 men and 9 women; mean age +/- SD, 61.9 +/- 5.9 y), including 23 patients with follow-up scans at 2 y. We derived (11)C-HED retention indices (RIs; mL of blood/min/mL of tissue) reflecting nerve density and integrity for 480 left ventricular (LV) sectors. We compared IPD patients with 33 healthy controls using z score analysis; RI values 30%, z score 9) occurred in 14 of 23 (60.9%) patients over 2 y, including percentage LV abnormality (59% increasing to 66%), z-severity (-2.4 down to -2.5), and SEP (-195 to -227) (P = 0.0062). We found a mean annual decline of 4.6% +/- 5.6 (maximum, 13%) in (11)C-HED retention from a baseline global RI mean of 0.0481 +/- 0.0218 to 0.0432 +/- 0.0220 (P = 0.0009). At baseline, 5 patients with normal uptake had no interval change; 3 with mild denervation developed interval decline in lateral and inferior segments (diff-SEP -82 to -99) compared with anterior and septal segments (-65 to -79), whereas the reverse pattern occurred in 15 patients with severe baseline denervation. CONCLUSION: Progressive decline in cardiac sympathetic neural integrity in IPD patients occurs at a modest rate over 2 y on (11)C-HED scans with marked heterogeneity and a regional pattern of involvement and decline. CI - (c) 2017 by the Society of Nuclear Medicine and Molecular Imaging. FAU - Wong, Ka Kit AU - Wong KK AD - Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, Michigan kakit@med.umich.edu. AD - VA Ann Arbor Healthcare System, GRECC, Ann Arbor, Michigan. FAU - Raffel, David M AU - Raffel DM AD - Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, Michigan. FAU - Bohnen, Nicolaas I AU - Bohnen NI AD - Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, Michigan. AD - VA Ann Arbor Healthcare System, GRECC, Ann Arbor, Michigan. AD - Functional Neuroimaging, Cognitive and Mobility Laboratory, Departments of Radiology and Neurology, University of Michigan, Ann Arbor, Michigan. AD - University of Michigan Morris K. Udall Center of Excellence for Parkinson's Disease Research, Ann Arbor, Michigan. FAU - Altinok, Gulcin AU - Altinok G AD - Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, Michigan. FAU - Gilman, Sid AU - Gilman S AD - Department of Neurology, University of Michigan (retired), Ann Arbor, Michigan; and. FAU - Frey, Kirk A AU - Frey KA AD - Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, Michigan. AD - Department of Neurology, University of Michigan, Ann Arbor, Michigan. LA - eng GR - P50 NS091856/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20160818 PL - United States TA - J Nucl Med JT - Journal of nuclear medicine : official publication, Society of Nuclear Medicine JID - 0217410 RN - 0 (Radiopharmaceuticals) RN - 3002-40-2 (3-hydroxyephedrine) RN - GN83C131XS (Ephedrine) SB - IM MH - Aged MH - Autonomic Nervous System Diseases/*diagnostic imaging/etiology MH - Disease Progression MH - Ephedrine/*analogs & derivatives MH - Female MH - Heart/*diagnostic imaging/*innervation MH - Humans MH - Longitudinal Studies MH - Male MH - Middle Aged MH - Parkinson Disease/complications/*diagnostic imaging MH - Positron-Emission Tomography/*methods MH - Radiopharmaceuticals MH - Reproducibility of Results MH - Sensitivity and Specificity PMC - PMC5288743 OTO - NOTNLM OT - 11C-hydroxyephedrine PET OT - Parkinson disease OT - autonomic nervous system OT - cardiac sympathetic denervation EDAT- 2016/08/20 06:00 MHDA- 2017/05/02 06:00 PMCR- 2017/08/01 CRDT- 2016/08/20 06:00 PHST- 2016/04/15 00:00 [received] PHST- 2016/07/21 00:00 [accepted] PHST- 2016/08/20 06:00 [pubmed] PHST- 2017/05/02 06:00 [medline] PHST- 2016/08/20 06:00 [entrez] PHST- 2017/08/01 00:00 [pmc-release] AID - jnumed.116.176891 [pii] AID - 176891 [pii] AID - 10.2967/jnumed.116.176891 [doi] PST - ppublish SO - J Nucl Med. 2017 Feb;58(2):326-331. doi: 10.2967/jnumed.116.176891. Epub 2016 Aug 18.